The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia
Abstract Background Cancer cachexia (CC) is a severe complication during the last stages of the disease, which is characterized by the substantial loss of muscle and fat mass. Currently, there is no effective treatment of CC. Erythropoietin plays tissue‐protective role in different tissues. Based on...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2022-08-01
|
| Col·lecció: | Journal of Cachexia, Sarcopenia and Muscle |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/jcsm.13009 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|